What Happened: The 7-OH Ban Timeline
If you sell kratom and haven't audited your product catalog since mid-2025, your merchant account is at serious risk. The FDA's recommendation to schedule concentrated 7-hydroxymitragynine (7-OH) as a Schedule I substance — combined with Mastercard's BRAM enforcement deadline — has created the most disruptive regulatory shift the kratom industry has faced. Merchants who don't act now face processor shutdowns, card brand fines, and permanent placement on the MATCH list.
Here is how the timeline unfolded:
July 2025: The FDA formally recommended Schedule I classification for concentrated 7-hydroxymitragynine. The FDA drew a critical distinction: natural kratom leaf products containing less than 2% 7-OH were treated separately from synthetic or concentrated formulations that can reach up to 98% 7-OH purity. This distinction matters for merchants because it determines which products you can still sell — and which ones will get your account terminated.
August 2025: Florida became the first state to classify concentrated 7-OH as a Schedule I controlled substance, triggering enforcement actions against retailers and online sellers operating in the state. Several other states began reviewing similar legislative measures.
August 15, 2025: Mastercard's Brand Risk and Acquirer Monitoring (BRAM) program issued a hard deadline for acquiring banks and payment processors to cease facilitating 7-OH kratom transactions. Violations after this date carry escalating fines and potential removal from the Mastercard network.
Late 2025 through 2026: Additional state-level actions continue. Alabama, Arkansas, Indiana, Rhode Island, Vermont, and Wisconsin maintain complete kratom bans covering all forms. Several states that previously allowed all kratom products have introduced legislation targeting concentrated 7-OH specifically, creating new compliance layers for merchants shipping across state lines.
What's Still Legal
Natural kratom leaf products remain legal at the federal level and in most U.S. states. The FDA's scheduling recommendation targets concentrated and synthetic 7-hydroxymitragynine — not the naturally occurring compound at trace levels in raw kratom leaf. If your business sells compliant leaf products, you have a path forward. But you need to understand where the line is drawn.
Here is the practical distinction:
- Legal in most states: Raw kratom leaf, powder, capsules, and standard extracts where 7-OH occurs naturally at concentrations below approximately 2%
- Targeted for scheduling or already banned: Concentrated 7-OH isolates, enhanced extracts marketed for 7-OH potency, 7-OH shots, 7-OH gummies, and synthetic 7-hydroxymitragynine
- Completely banned (all kratom forms): Alabama, Arkansas, Indiana, Rhode Island, Vermont, Wisconsin
If your catalog consists entirely of natural kratom leaf products and you do not sell into banned states, your legal standing has not changed. But your payment processing situation may have — because processors and card brands do not always make the same nuanced distinction the FDA does. Your acquiring bank may treat all kratom merchants as elevated risk until you prove your product catalog is clean. For details on what processors look for, see our kratom payment processing guide.
How This Affects Payment Processing
67% of kratom merchants experience at least one processor shutdown within two years — and that statistic predates the 7-OH enforcement wave. The current environment is significantly worse for merchants who have not adapted their catalogs and compliance documentation.
Payment processors evaluate kratom merchants based on regulatory risk, chargeback history, and card brand compliance. The 7-OH ban introduced a new variable: product-level compliance. It is no longer enough to be a "kratom merchant" with a compliant website. Processors and acquiring banks now want line-item assurance that no concentrated 7-OH products exist in your catalog, your marketing, or your transaction descriptions.
What has changed for processors since the ban:
- Heightened underwriting scrutiny: New applications and renewals now face deeper product catalog reviews. Acquiring banks want itemized product lists with lab certificates of analysis (COAs) confirming 7-OH concentrations at naturally occurring levels.
- Active MID monitoring: Processors are scanning merchant websites, product pages, and social media for any 7-OH references — including historical content like old blog posts or archived product pages.
- Retroactive terminations: Some processors have terminated merchants who previously sold 7-OH products, even when those products were removed before the August deadline. The processing history itself becomes a risk flag.
- Tighter reserve requirements: Even compliant kratom merchants are seeing rolling reserves increase from the typical 10–15% range toward 15–20% as acquirers price in the heightened regulatory uncertainty.
If you are currently processing kratom payments, your immediate priority is confirming your compliance status with your processor before they audit you. Proactive communication is always better than a surprise hold or termination.
Mastercard BRAM Enforcement
Mastercard's Brand Risk and Acquirer Monitoring (BRAM) program is the enforcement mechanism that gives the 7-OH ban real teeth in the payments world. Understanding how BRAM works explains why processors are reacting so aggressively — and what you can do about it.
BRAM targets acquiring banks, not merchants directly. When Mastercard identifies non-compliant transactions flowing through an acquirer, that acquirer faces fines escalating with each violation cycle. Acquirers pass this liability downstream to processors and ultimately to merchants. The practical result: processors would rather terminate a kratom merchant preemptively than risk a BRAM inquiry.
The August 15, 2025 deadline was not a soft date. Processors that continued facilitating 7-OH transactions after this date entered Mastercard's formal enforcement pipeline. Fines can reach $25,000–$100,000+ per violation cycle, and repeated violations risk the acquirer losing its Mastercard license entirely — which is why no processor treats 7-OH compliance casually.
What BRAM means for your merchant account:
- Your acquiring bank is being actively monitored for 7-OH-related transactions
- Product descriptions, MCC codes, or marketing materials referencing 7-OH can trigger a BRAM inquiry
- Your processor may request updated product catalogs, COAs, and website screenshots as part of ongoing compliance verification
- Non-response to compliance requests is treated the same as non-compliance
For merchants selling natural kratom leaf products with no concentrated 7-OH, the key is documentation. Your processor needs proof your products fall outside the enforcement category. See our kratom merchant account requirements for the full documentation checklist.
Product Catalog Audit Checklist
If you sell any kratom products, run this audit now — before your processor does it for you:
1. Remove all concentrated 7-OH products from your store immediately — isolates, enhanced extracts marketed for 7-OH content, 7-OH shots, and 7-OH gummies 2. Pull marketing materials that reference 7-OH potency, concentration levels, or synthetic mitragynine analogs from product pages, ads, and social media 3. Obtain certificates of analysis (COAs) from accredited third-party labs for every kratom product in your catalog, confirming 7-OH is present only at naturally occurring levels (below 2%) 4. Update product descriptions to remove any 7-OH claims, including historical references in blog posts, FAQ pages, or email campaigns 5. Review billing descriptors — ensure your transaction descriptions do not include "7-OH," "7-hydroxymitragynine," or similar terms that could flag BRAM monitoring 6. Verify shipping restrictions — confirm you are blocking orders to banned states (Alabama, Arkansas, Indiana, Rhode Island, Vermont, Wisconsin) at checkout 7. Archive compliance evidence — save dated screenshots of your cleaned product pages, shipping restriction settings, and COAs so you can respond immediately if your processor requests documentation
Merchants who complete this audit and share documentation proactively with their processor are far less likely to face involuntary termination. If your processor has not asked yet, reach out first. If you need help setting up compliant processing, contact Unison.
How to Keep Your Kratom Merchant Account
The kratom merchants who survive regulatory shifts are the ones who treat compliance as an ongoing operation — not a one-time cleanup. Here is what that looks like in practice:
Work with a processor that understands kratom
Generic high-risk processors often approve kratom merchants but lack the underwriting depth to distinguish between compliant natural leaf products and concentrated 7-OH. When BRAM enforcement hits, these processors terminate everyone rather than evaluate case by case. A kratom merchant account through a specialized provider gives you access to acquiring banks that understand the distinction and will work with you through regulatory changes instead of cutting you loose.
Maintain chargeback ratios below 1%
Even with perfect product compliance, elevated chargebacks give your processor justification to terminate. Invest in chargeback protection tools like Ethoca and Verifi alerts, use clear billing descriptors, and publish transparent refund policies. Typical processing rates for kratom merchants run 3.5–5.5% + $0.20–$0.30 per transaction with 10–15% rolling reserves. These costs are manageable compared to losing processing entirely.
Use a compliant payment gateway
Your kratom payment gateway needs to support age verification, state-level shipping restrictions, and product-level transaction data. These are not optional features — they are what processors use to verify ongoing compliance and what protect you during BRAM audits.
Diversify your processing
Do not rely on a single merchant account. If your volume supports it, maintain a backup processing relationship so one termination does not shut your business down overnight. ACH and eCheck processing provides a secondary payment rail that is not subject to card brand BRAM enforcement and often carries lower dispute dynamics.
Bottom Line
The 7-OH ban is not a kratom ban — but merchants who ignore the distinction risk losing their ability to process payments entirely. The regulatory and payment landscape shifted permanently in 2025. Concentrated 7-OH products are now in the same enforcement category as controlled substances for payment processing purposes. Natural kratom leaf products remain processable through properly underwritten high-risk merchant accounts with processors who understand the difference.
If you are a kratom merchant, the path forward is straightforward: audit your catalog, document your compliance, communicate proactively with your processor, and work with a payment partner that specializes in this space. Waiting for your processor to audit you first is how merchants end up on the MATCH list with frozen funds and no backup plan.
**Contact Unison →** to review your kratom processing compliance or apply for a merchant account built for this regulatory environment.